rss
Arch Dis Child Fetal Neonatal Ed 2001;84:F188-F193 doi:10.1136/fn.84.3.F188
  • Original article

Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants

  1. K Hirano,
  2. T Morinobu,
  3. H Kim,
  4. M Hiroi,
  5. R Ban,
  6. S Ogawa,
  7. H Ogihara,
  8. H Tamai,
  9. T Ogihara
  1. Department of Pediatrics, Division of Neonatology, Osaka Medical College, Osaka, Japan
  1. Dr Ogihara, Department of Pediatrics, Osaka Medical College, 2–7, Daigaku-machi, Takatsuki, Osaka 569-8686, Japanped025{at}poh.osaka-med.ac.jp
  • Accepted 20 December 2000

Abstract

BACKGROUND Blood transfusion has been recognised as a risk factor for the development of retinopathy of prematurity (ROP) or chronic lung disease (CLD) in preterm infants, but the precise mechanism involved is not understood.

AIM To investigate the level of non-transferrin bound “free” iron, which has the potential to promote the generation of reactive oxygen species, and its redox status in the plasma of preterm infants immediately before and after blood transfusion.

METHODS Twenty one preterm infants with a median gestational age and birth weight of 27 weeks and 1021 g respectively were prospectively enrolled in the study. Sixteen of the 21 infants developed ROP and/or CLD. The infants were transfused with concentrated red blood cells at a median age of 32 days. The plasma concentration of total bleomycin detectable iron (BDI) was measured and also the ferrous iron (Fe2+) activity by bleomycin-iron complex dependent degradation of DNA.

RESULTS Even before blood transfusion, BDI was detectable in one third of the blood samples, and all but one sample had ferrous iron activity. After transfusion, both BDI and ferrous iron activity were significantly increased, in contrast with the situation in full term infants. Plasma ascorbic acid (AA) concentration was significantly decreased after blood transfusion, whereas the level of its oxidation product, dehydroascorbic acid (DHAA), and the DHAA/AA ratio were significantly increased compared with before the transfusion. The activity of plasma ferroxidase, which converts iron from the ferrous to the ferric state, was appreciably decreased in preterm infants, as expected from their very low plasma caeruloplasmin concentration.

CONCLUSIONS Plasma non-transferrin bound iron was significantly increased in preterm infants after blood transfusion and existed partly in the ferrous form, because of the low ferroxidase activity and the reduction of ferric iron (Fe3+) by ascorbic acid. This finding was specific to preterm infants and was not observed in full term infants after blood transfusion. Non-transferrin bound “free” iron may catalyse the generation of reactive oxygen species, which may be responsible for the clinical association of blood transfusion with ROP and CLD.

  • Plasma non-transferrin bound iron was significantly increased in preterm infants after blood transfusion and existed partly in the ferrous pro-oxidant form

  • The increase in plasma non-transferrin bound iron after blood transfusion was not observed in full term infants

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.